SCHEMBL7008960

SCHEMBL7008960

O=c1[nH]c2ccccc2c(=O)n1C1CC[N]CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
CA12 O43570 1/20 0.47
RNASEH1 O60930 1/20 0.47
ERCC1 P07992 1/20 0.47
ERCC5 P28715 1/20 0.47
FEN1 P39748 1/20 0.47
CA9 Q16790 1/20 0.47
ERCC4 Q92889 1/20 0.47
HTT P42858 4/20 0.45
LMNA P02545 2/20 0.45
ALOX12 P18054 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6243579 0.89 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL30858360 0.89 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL6982576 0.85 CHRM2 (0.58) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL3960105 0.84 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL791221 0.82 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL220219 0.82 CHRM1 (0.62) CYP2C9CHRM2CHRM4CHRM1CHRM3
SCHEMBL13801259 0.80 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL14410199 0.78 OPRM1 (0.56) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL12510191 0.77 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL14417155 0.77 CHRM1 (0.56) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163239-B1 MODIFIED AMINO-ACID AMIDES AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-28 EP disclosed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US disclosed